Curriculum Vitae

DR. JESINDA PAULINE A/P KERISHNAN

Research Officer
  • Department of Medicine
    Faculty of Medicine
  • jesindapaul
  • 0379672421

ACADEMIC QUALIFICATION


  • DOCTOR OF PHILOSOPHY, (Oral Oncology)
    Universiti Malaya
  • BACHELOR IN BIOMEDICINE (HONOURS), (Bioperubatan)
    Kolej Universiti Teknologi & Pengurusan Malaysia
  • DIPLOMA TEKNOLOGI MAKMAL PERUBATAN, (Teknologi Makmal Perubatan)
    Pusat Teknologi dan Pengurusan Lanjutan

ADMINISTRATIVE DUTIES


  • JAWATANKUASA IJAZAH TINGGI (JKIT) - Postgraduate Coordinator Jabatan Perubatan
    01 Jun 2022 - 31 May 2024 (Department of Medicine, Faculty of Medicine)
  • International Mt. Hood Diabetes Challenge Network Conference and the Society of Medical Decision-Making Conference 2023, 3rd – 5th December 2023, Nexus, Bangsar South, Connexion Conference& Event Center, Kuala Lumpur.
    17 May 2023 - 05 Dec 2023 (International)
  • Department of Medicine UM Masterclass in Medicine 2023, 23rd – 24th September 2023, Avante Hotel, Bandar Utama, Petaling Jaya
    29 Jan 2023 - 25 Sep 2023 (Department)
  • Department of Medicine Postgraduate Short Case Preparatory Course (UM Masterclass in Medicine 2023), 25th September 2023, Universiti Malaya Medical Center, Kuala Lumpur
    29 Jan 2023 - 25 Sep 2023 (Department)
  • Advisor MRCP (UK) PACES Coordinating Committee Malaysia
    01 Aug 2022 - 31 Aug 2023 (International)
  • Seminar Organiser: 'Latest Genomics Technologies in Cancer Research'; by Dr. Chen Chao (BGI Tech Solution Co., Ltd) Lecture Room (Level 9), Postgraduate and Research Tower, Faculty of Dentistry, UM, 20/06/2014.
    26 Jun 2014 - 26 Jun 2014 (Faculty)

MEMBERSHIPS


  • MEMBER OF PHLEBOTOMY ASSOCIATION OF MALAYSIA, MEMBER
    Since 2013 (National)

AWARD AND STEWARDSHIP


  • 1st Prize Oral Presentation
    Universiti Malaya, 2018 (International)

PUBLICATIONS


Article in Journal
WoS
  1. Zhang, Qinyi; Teow, Jun Yao; Kerishnan, Jesinda Pauline; Abd Halim, Adyani Azizah; Chen, Yeng (2023). Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review, BIOMEDICINES. 11(5). doi:10.3390/biomedicines11051458
  2. Kerishnan, J. P., Mah, M. K., Fawzi, N., Ramanathan, A., Lim, G. S., Aziz, A. A., . . . Chen, Y. (2019). The Association between Epstein-Barr virus (EBV) Past Infection with the Risk of Oral Squamous Cell Carcinoma (OSCC). Sains Malaysiana, 48(9), 1969-1974. doi:10.17576/jsm-2019-4809-18
  3. Gopinath, Subash C. B.; Lakshmipriya, Thangavel; Chen, Yeng; Arshad, M. K. Md; Kerishnan, Jesinda P.; Ruslinda, A. R.; Al-Douri, Y.; Voon, C. H.; Hashim, Uda (2016). Cell-targeting aptamers act as intracellular delivery vehicles, APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. 100(16), 6955-6969. doi:10.1007/s00253-016-7686-2
  4. Kerishnan, Jesinda P.; Gopinath, Subash C. B.; Kai, Sia Bik; Tang, Thean-Hock; Ng, Helen Lee-Ching; Rahman, Zainal Ariff Abdul; Hashim, Uda; Chen, Yeng (2016). Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor, INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. 13(6), 424-431. doi:10.7150/ijms.14475
  5. Kerishnan, Jesinda P.; Mohammad, Sani; Alias, Muhamad Shaifunizam; Mu, Alan Kang-Wai; Vaithilingam, Rathna Devi; Baharuddin, Nor Adinar; Safii, Syarida H.; Rahman, Zainal Ariff Abdul; Chen, Yu Nieng; Chen, Yeng (2016). Identification of biomarkers for periodontal disease using the immunoproteomics approach, PEERJ. 4. doi:10.7717/peerj.2327
  6. Chen, Yeng; Chan, Choon K.; Kerishnan, Jesinda P.; Lau, Yee L.; Wong, Yin-Ling; Gopinath, Subash C. B. (2015). Identification of circulating biomarkers in sera of Plasmodium knowlesi-infected malaria patients - comparison against Plasmodium vivax infection, BMC INFECTIOUS DISEASES. 15. doi:10.1186/s12879-015-0786-2
  7. Chen, Yeng; Azman, Siti Nuraishah; Kerishnan, Jesinda P.; Zain, Rosnah Binti; Chen, Yu Nieng; Wong, Yin-Ling; Gopinath, Subash C. B. (2014). Identification of Host-Immune Response Protein Candidates in the Sera of Human Oral Squamous Cell Carcinoma Patients, PLOS ONE. 9(10). doi:10.1371/journal.pone.0109012

PAPER PRESENTED


ORAL PRESENTER
  1. Discovery of Potential Biomarkers in Oral Squamous Cell Carcinoma Using Next Generation Sequencing Technology., International Conference on Oral Immunology & Oral Microbiology (ICOIOM), Malaysian Society of Oral Microbiologies & Oral Immunologiest (International) (14 Aug 2018 - 15 Aug 2018)
  2. Molecular Landscape of Oral Squamous Cell Carcinoma through Next Generation Technology., Dental Congregation 2016, Faculty of Dentistry (University) (13 Aug 2016 - 14 Aug 2016)
  3. Mutation Landscape of Oral Squamous Cell Carcinoma Through the Use of Next Generation Technology., Three minute thesis (3MT), Faculty of Dentistry, Universiti Malaya (University) (20 May 2016 - 20 May 2016)
  4. Mutation Landscape of Oral Squamous Cell Carcinoma Through the Use of Next Generation Technology, Three minute thesis (3MT), Faculty of Dentistry, University of Malaya (University) (21 May 2015 - 21 May 2015)
POSTER PRESENTER
  1. Evaluation of Human Papilomavirus Antibodies as Oral Squamous Cell Carcinoma Risk Factors Indicator., 28th Annual Scientific Meeting of the International Association for Dental Research Southeast Asian Division (IADR-SEAADE, 2014), IADR-SEAADE (International) (11 Aug 2014 - 14 Aug 2014)
  2. Detection of Parasite and Host-Specific Proteins in the Sera of Individuals Infected with Plamodium knowlesi', 8th European Congress on Tropical Medicine and International Health, Copenhagen, Denmark, European Congress on Tropical Medicine and International Health (International) (08 Sep 2013 - 14 Sep 2013)